Helge Lund

Helge Lund is a prominent Norwegian business executive renowned for his transformative leadership in the global energy industry. He served as the chief executive officer of both Statoil (now Equinor) and the UK-based BG Group, steering these major corporations through periods of significant strategic change. His career is distinguished by high-profile roles in oil and gas and his subsequent chairmanships of leading global pharmaceutical companies, Novo Nordisk and Bristol-Myers Squibb.

Early life and education

Helge Lund was born in Oslo and demonstrated an early aptitude for academics and leadership. He pursued his higher education at the prestigious Norwegian School of Economics (NHH) in Bergen, where he earned a Siviløkonom degree, a foundational step for many of Scandinavia's top business leaders. Following his initial studies, Lund furthered his education internationally, attending the Sloan School of Management at the Massachusetts Institute of Technology (MIT) in the United States. At MIT, he completed a master's degree as part of the renowned Sloan Fellows Program, an experience that provided him with advanced management training and a global network.

Career at Aker and Statoil

Lund began his professional career as a management consultant at McKinsey & Company, working in their Oslo office. He then moved to the industrial conglomerate Aker ASA, where he held several executive positions, including CEO of its subsidiary Aker RGI. His performance at Aker brought him to the attention of the board of the state-owned energy giant Statoil. In 2004, Lund was appointed President and CEO of Statoil, succeeding Olav Fjell. His tenure was marked by a strong focus on international expansion and operational efficiency, overseeing major projects like the Snøhvit LNG field and navigating the complexities of the Goliat development. He also played a key role in Statoil's strategic merger with the oil and gas division of Norsk Hydro in 2007, creating a national energy champion.

BG Group and Equinor leadership

In a notable cross-border move, Lund left Statoil in 2014 to become the Chief Executive of the British multinational BG Group, succeeding Chris Finlayson. His appointment was seen as a stabilizing force for BG Group following operational challenges. Lund's primary task was to oversee the company's large-scale LNG projects, including those in Australia and Brazil, and to improve its financial performance. His most significant achievement at BG Group was orchestrating its £35 billion acquisition by Royal Dutch Shell in 2016, one of the largest deals in energy industry history. Following the acquisition, he returned to Norway and served as the Chair of the Board of Directors for the renamed Equinor from 2018 to 2020, guiding the company's early strategic pivot towards renewable energy.

Other board positions and roles

Beyond his executive roles in energy, Helge Lund has built a distinguished career as a board director and chairman for several blue chip international corporations. He has served as a board member for Schlumberger, one of the world's largest oilfield services companies, and for the industrial investment firm Investor AB, controlled by the Wallenberg family in Sweden. His most prominent board leadership roles began with his election as Chairman of the Danish pharmaceutical company Novo Nordisk in 2017, succeeding Göran Ando. In 2023, he assumed the additional role of Chairman of the American biopharmaceutical leader Bristol-Myers Squibb, taking over from Giovanni Caforio. He also chairs the Royal Swedish Academy of Engineering Sciences and serves on the International Advisory Board of the BP plc.

Personal life and recognition

Helge Lund is married to Kjersti Lund, and the couple has three children. He maintains a relatively private personal life but is known within business circles for his analytical and strategic mindset. Throughout his career, Lund has received significant recognition for his leadership. He has been consistently ranked among the world's best-performing CEOs by the Harvard Business Review. In 2008, he was honored as a Commander with Star of the Order of St. Olav by King Harald V of Norway for his contributions to Norwegian business and industry. His legacy is that of a respected global executive who successfully navigated the peaks of the oil and gas sector before transitioning to leadership roles in the vital healthcare industry.

Category:Norwegian businesspeople Category:1962 births Category:Living people Category:Equinor people Category:Norwegian School of Economics alumni Category:Massachusetts Institute of Technology alumni